Eucrates Biomedical Acquisition Corp.
The momentum for this stock is not very good. Eucrates Biomedical Acquisition Corp. is not very popular among insiders. Tradey thinks it is not wise to invest in Eucrates Biomedical Acquisition Corp..
Log in to see more information.
News
Eucrates Biomedical Acquisition Corp. Announces Liquidation
PR Newswire Eucrates Biomedical Acquisition Corp. Announces Liquidation Eucrates Biomedical Acquisition Corp. Announces Liquidation PR Newswire NEW YORK, April 11, 2023 NEW YORK, April 11, 2023 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the 'Company') announced the...\n more…